WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Tuesday reported a loss of $16.9 million in its first quarter.

The Wayne, Pennsylvania-based company said it had a loss of 24 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.

The specialty pharmaceutical company posted revenue of $2.4 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $2 million.

In the final minutes of trading on Tuesday, the company's shares hit $1.36. A year ago, they were trading at $8.40.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS